ALKEMNSEAlkem Laboratories LimitedLowNeutral
Announced Mon, 19 May · 17:39 IST

Alkem Laboratories Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

ALKEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Alkem Laboratories has informed the exchanges about a conference call scheduled for Thursday, May 29, 2025, at 4:30 PM IST to discuss its Q4 FY25 and full-year FY25 financial results. The call will be hosted by Motilal Oswal Securities and will be attended by CEO Dr. Vikas Gupta and CFO Mr. Nitin Agrawal. The conference call will take place on the same day as the company's Q4 and FY25 results announcement. Investors and analysts can join via Indian dial-in numbers or international toll-free lines (USA, UK, Singapore, Hong Kong), or via a Diamond Pass link.

Likely market impact

This is a routine investor engagement filing and by itself is not price-moving. However, the Q4 and FY25 results being released on the same day, along with management's outlook commentary during the call, could be significant for the stock and may drive short-term volatility.